Background: Primary evaluation of patients with pulmonary atresia with ventricular septal defect (PA-VSD) traditionally relies upon echocardiography and conventional cardiac angiography (CCA
INTRODUCTION
Pulmonary atresia with ventricular septal defect (PA-VSD) belong to a group of congenital cardiac malformations characterised by the lack of luminal continuity and blood flow from either the ventricle and the pulmonary artery, together with ventricular septal defect [5, 6, 10, 17, 22] . The pulmonary circulation in PA-VSD can be supplied with native pulmonary arteries, systemic circulation from patent ductus arteriosus (PDA) or major aortopulmonary collateral arteries (MAPCAs), or a combination of the two [6, 15, 22] . Major aortopulmonary arteries are large systemic collateral arteries, typically one to six in number but sometimes more, usually originating from the descending thoracic aorta [11] . Occasionally they arise from subclavian artery, aortic arch or abdominal aorta or uncommonly from other systemic arteries such as carotid, or coronary arteries [11, 22] . They most commonly terminate by joining an interlobar or intralobar pulmonary artery that arborizes normally within a pulmonary lobe or segment, but they distribute distally into the lungs and do not communicate with the central pulmonary artery system in some cases [11] . Most patients with PA-VSD have a diffusely enlarged network of bronchial arteries providing a nondiscrete source of the pulmonary circulation [11] . They are usually smaller and more numerous than MAPCAs [11, 22] . Nonbronchial systemic arteries, such as the paramediastinal collateral arteries and the intercostals collateral arteries, also supply the lungs [11] . The morphology of these vessels can be highly complex by nature, and they can undergo changes during the course of disease.
Some progress to stenosis and complete occlusion, and others without stenoses usually become hypertensive [3] . On the basis of the characterisation of the pulmonary circulation, PA-VSD is classified into three types [22] . In type A, the native pulmonary arteries are present and are supplied by the PDA. In type B, pulmonary blood flow is provided by both native pulmonary arteries and by MAPCAs. In type C, native pulmonary arteries are absent and the blood supply is only through MAPCAs. When surgical management of PA-VSD is possible, MAPCAs are unified at the hilum, right ventricular pulmonary arterial continuity is established, and the VSD is closed [11, 19] .
Primary evaluation of patients with PA-VSD traditionally relies upon echocardiography and conventional cardiac angiography, both of which have potential limitations [1, 14] . Echocardiography is an operator dependent and limited by small window.
Furthermore, echocardiography does not provide the surgeon with a precise anatomical roadmap. Although conventional cardiac angiography (CCA) has long been accepted for preoperative evaluation to obtain an accurate map of pulmonary circulation, it is an invasive procedure with a risk of catheter complications. Both surgery and endovascular interventions are not always feasible and are associated with complications [3, 11, 19] .
The use of multidetector-row computed tomography angiography (MDCT) for evaluation of MAPCAs has been reported with older-generation scanners using three-dimensional (3D) imaging software, a complex pulmonary blood supply can noninvasively and accurately imaged with high-resolution MDCT [2, 12, 13, 16] . Precise characterisation of the condition of pulmonary arteries and MAPCAs is of paramount importance in managing patients with PA-VSD. Development of newer scanner such as dual-source MDCT uses two X-ray tubes and detectors to achieve an improved temporal resolution of 83 ms. with a gantry rotation time of 330 ms with use of a single-segment reconstruction mode [20] . This newer scanner MDCT provides an alternative to alleviate these pitfalls of traditional cardiac diagnostic studies. Therefore, the purpose of the current study was to evaluate the diagnostic accuracy of dual source MDCT in the identification and the comprehensive evaluation of patients with PA-VSD compared with CCA as the standard of reference.
MATERIALS AND METHODS

Patient population
This retrospective study included 28 patients with diagnosis of PA-VSD who underwent both MDCT and CCA, between February 2013 and December 2014. The indications for MDCT were preoperative evaluation of PA-VSD patients which is considered appropriate indications for MDCT, based on the criteria of the American College of Cardiology (ACC) [21] . Exclusion criteria for MDCT included the presence of renal failure, and a history of allergic reaction to iodine-containing contrast agents.
Dual-source MDCT scanning protocol
Short-term IV sedation is often required, particularly in children under 5 years of age, and the imaging can be performed during quiet breathing. Imaging was performed by using a dual-source MDCT scanner (Somatom Definition; Siemens Healthcare, Forchheim, Germany). The radiation dose is kept to minimum by reducing the kilovoltage and tube current appropriately. For children weighing less than 10 kg, 10-19 kg and 20-30 kg, we use 80 kV and 80 mAs, 80 kV and 100 mAs, and 100 kV and 120 mAs, respectively. Other cardiac computed tomography angiographic parameters were as follows: number of X-ray tubes, two; collimation, 128 detector rows of 0.5 mm each, with double sampling by using rapid alteration of the focal spot in the longitudinal direction (z flying focal spot) [7] . Prior to scanning, the pitch was set automatically by the scanner software. Depending on heart rate, pitch was set between 0.2 and 0.43. Automated dose regulation methods such as CARE dose 4D (Siemens Healthcare) may be used to reduce the radiation.
Image acquisition was performed during inspiratory breath-hold for older children or adult. To familiarise the patient with the protocol, breath-holding was practiced before the examination. A bolus of iodinated contrast material (350 mg/mL, Omnipaque; GE Healthcare) at a dose of 1.5 mL/kg with dualhead power injector at a rate of 1.5-2.0 mL/s for a 22-gauge cannula, 3.0 mL/s for a 20-gauge cannula and 4.0-5.0 mL/s for a 18-gauge cannula followed by a 10-20 mL of saline flush at a same rate to that of the contrast injection. For timing purposes, an automated bolus-tracking software was used, starting the scan automatically 6 s after contrast agent density in the descending aorta reached a predefined threshold of 130 HU [4] . The entire volume of the heart and pulmonary arteries was covered during one breath-hold in approximately 5 s with simultaneous recording of the electrocardiography trace. Patients were scanned in the supine position. MDCT is performed from the thoracic inlet level to L1-L2. When there is suspicion of anomalous pulmonary venous drainage, the scan can be extended down to the lower border of the liver.
MDCT image analysis
MDCT image analysis was performed by two cardiovascular and thoracic radiologists in consensus (with a respective 11 and 10 years of experience in examining cardiovascular and thoracic computed tomography scans) and blinded to the clinical data and the results of CCA data. First, axial all image data are evaluated using a 3D post processing workstation with Syngo software (Siemens Healthcare). Various image reformatting techniques including curved planar reconstruction, maximum intensity projection (MIP), minimum intensity projection, and volume-rendering technique (VRT) are used to get all the clinically relevant information. Curved planar reformatting and MIP are primarily used to evaluate curved structures such as the pulmonary arteries and MAPCAs. Minimum intensity projection is used to evaluate the airway and lung parenchyma. For 3D reformatting of the complex anatomy, the VRT is used. Thin-section multiplanar reformatting is used for quantitative analysis of the structure in question.
On the basis of the characterisation of the pulmonary circulation, PA-VSD is classified into three types. In type A, the native pulmonary arteries are present and are supplied by the PDA. In type B, pulmonary blood flow is provided by both native pulmonary arteries and by MAPCAs. In type C, native pulmonary arteries are absent and the blood supply is only through MAPCAs [11, 17, 22] as illustration shown on Figure 1 . 
Conventional coronary angiography
Conventional coronary angiography was performed according to standard techniques. Images were evaluated by an experienced cardiologist blinded to MDCT results using a validated and dedicated quantitative coronary angiography (QCA) software package (CA-CMS, QAngioXA 6.0, Medis Medical Imaging Systems, Leiden, The Netherland).
Statistical analysis
Sensitivity, specificity, and positive predictive value (PPV) and negative predictive value (NPV), including 95% confidence intervals (CI), for the detection of > 50% luminal narrowing of pulmonary artery were considered positive (> 50% luminal narrowing) on CCA. Continuous data were expressed as mean ± standard deviation (SD). Statistical analyses were performed using SPSS software version 16 (SPSS, Inc., Chicago, IL, USA). A significance level of p < 0.05 was considered a statistically significant result and all reported p-values were two-sided. Means were compared using unpaired t-test, and Mann-Whitney rank sum was used when data was not normally distributed.
RESULTS
Patient clinical characteristics are presented in Table 1 . Twenty-eight patients (10 boys, 18 girls; mean age, 9 ± 8 years; range, 3-14 years) were included in this study over a period of 22 months. The mean time interval between MDCT and CCA was 3 ± 10 days (range, 2-21 days) and there were no clinical events between the two studies in any patient. In most patients (25/28), MDCT was performed before CCA, and in 3 patients, CCA was performed first.
In patient analysis, out of 28 MDCT examinations, none of them was of non-diagnostic image quality. CCA identified 20 patients with confluent pulmonary arteries. All patients (100%) were correctly identified by MDCT. In addition, in a total of 28 patients, MDCT correctly identified the presence of non-confluent pulmonary arteries in 8 patients. Importantly, no patients with non-confluent pulmonary arteries were missed by MDCT. Therefore, the sensitivity and specificity for the detection of confluent or non-confluent pulmonary arteries were all 100%. In addition, PPV and NPV were all 100%.
Five patients had complete absence of native pulmonary artery and 3 patients had stenosis of proximal branches of pulmonary arteries; all had MAPCAs from descending thoracic aorta and/or subclavian arteries.
In a total of 28 patients, 3 patients were correctly classified as PA-VSD type A on MDCT (Fig. 2 , true positive), whereas 20 patients were correctly classified as PA-VSD type B on MDCT and 5 patients were correctly classified as PA-VSD type C on MDCT. Consequently, the sensitivity, specificity, PPV and NPV for the classification of PA-VSD were all 100%.
For pulmonary collateral vessels evaluated, no statistical significant of a total of 84 collateral vessels were identified on MDCT and 85 collateral vessels were identified on CCA (p = 0.78).
MDCT was equivalent to CCA to identification of PDA, 3 PDA were identified on both MDCT and CCA (p = 1). No statistical significant of MDCT and CCA to identified MAPCAs (MDCT = 81 vessels, CCT = 82 vessels, p = 0.86). The MAPCA was incorrectly identified by MDCT in only 1 vessel resulting in a sensitivity and specificity of 98.7% and 100%, respectively, and PPV and NPV were 100% and 98.7%, respectively. The diagnostic accuracy for the detection of confluent pulmonary arteries, PDA and MAPCAs as Table 2 .
DISCUSSION
The present study demonstrated excellent diagnostic accuracy for the comprehensive assessment of patient with PA-VSD using dual-source MDCT. Importantly, no patients with absence of native pulmonary artery or non-confluent pulmonary artery were missed using dual-source MDCT.
Furthermore, the excellent sensitivity, specificity, PPV and NPV suggests that MDCT might be particularly valuable in the evaluation of pulmonary collateral vessels such as PDA or MAPCAs compared with conventional cardiac angiography. These results are in line with previous published data on the performance of the older generation computed tomography scanner [2, 12, 13, 16] .
Analysis of the pulmonary artery anatomy is the most important aspect of diagnostic imaging of patients with PA-VSD. Various studies have shown that MDCT is an accurate tool for evaluating pulmonary arteries [4, 12, 13] . The presence or absence of native pulmonary artery, length of the pulmonary atresia, confluence of native main pulmonary arteries, size of main, right, and left pulmonary arteries at the origin and at prebranching site were recorded. Images were carefully analysed for branch pulmonary artery stenosis [18] . In patients with PA-VSD, the lungs can derive their blood supply from various sources [11, 17, 22] . MAPCAs represent fetal primitive intersegmental arteries that originate from the descending aorta and have not involuted. They gain access to the lung through the hilum and connect with native pulmonary arteries in the mediastinum or at the lobar or subsegmental level. MAPCAs are different from bronchial arteries in a number of ways [8] . Usually, MAPCAs do not branch in their mediastinal course, whereas bronchial arteries provide mediastinal branches and, in some cases, branches to the spinal cord. MAPCAs anastomose with the intrapulmonary arteries typically at or near the pulmonary hilum instead of in the periphery. MAPCAs may accompany bronchi but do not form a nutritive plexus around bronchi. Unlike bronchial arteries, MAPCAs are virtually never connected to intercostals arteries. Most MAPCAs have an elastic wall structure resembling the pulmonary artery or aorta rather than bronchial arteries. MDCT with 3D VRT has the potential to elucidate all the MAPCAs shown by invasive catheter angiography [8, 9, 16] . Using various MDCT post processing techniques, the total number of MAPCAs and their origin, course, and intrapulmonary connections can be easily assessed. PDA, if present, is an important source of pulmonary blood supply. When ductus arteriosus is patent, generally the native pulmonary arteries will be of adequate size. When a PDA connects with a central pulmonary artery, the peripheral distribution is normal, and there are no MAPCAs in that hemithorax. Thus, a PDA does not coexist with MAPCAs in the same lung [22] . Unlike MAPCAs, the ductus does not branch before joining the central pulmonary arteries, and it tends to be less tortuous. There is a high risk of stenosis of the pulmonary arteries at the PDA insertion site. Clinical progress by the development of MDCT technology beyond 4 slices can more likely be expected from increased temporal resolution which reduces cardiac motion artifacts and increased spatial resolution rather than from only increase in the volume coverage speed. The limitations of earlier MDCT systems in the assessment of cardiac and pulmonary arteries are the consequence of partial volume effects and beam-hardening artifacts which could be overcome by a higher isotropic spatial resolution. The total scanning time for a dual-source MDCT is shortened to approximately 5 s. Accordingly, faster image acquisition allows for a reducing the volume of contrast media and breath-hold time causing reducing respiratory motion artifacts, and making the technique more robust [4, 7, 8, 9, 18] .
Despite promising initial results, our study has potential limitations. First, since our method of enrollment included some patients who underwent CCA because of MDCT results, selection bias in a proportion of patients may have overestimated the calculated sensitivity of MDCT. However, selection bias tends to underestimate specificity, which was still high in our study, and may have had minimal effect on PPV and NPV because patient enrollment after initial MDCT was independent of the actual true disease status on CCA. Secondly, the present result is limited by the number of patients, therefore, the interpretation of sensitivity may be limited. Thirdly, our results represent a single-center experience, the generalisability of the present results is limited.
CONCLUSIONS
Dual-source MDCT provides a comprehensive evaluation of different anatomic structures, including the heart, pulmonary and systemic thoracic vasculature when evaluating patients with PA-VSD. In a clinical setting, MDCT has proved to be an invaluable diagnostic and decision-making tool as a compliment to echocardiography and increasingly as a substitute for invasive angiography. The advantage of MDCT compared with CCA is that it is noninvasive, allows avoiding most catheter-associated risks and discomforts with the exception of exposure to iodinated contrast agents and radiation. With rapidly improving technology, MDCT may well evolve from a useful complement to CCA to a clinically viable alternative.
